Group B Streptococcus Prophylaxis During Labour

Group B Streptococcus (GBS), also called Streptococcus agalactiae, commonly lives in the bowel and genital tract without causing symptoms. During labour, however, it can pass to a newborn and cause early-onset disease, including sepsis, pneumonia or meningitis. The central prevention strategy is giving an effective antibiotic during labour when a pregnant patient has an identified or significant risk of GBS transmission.

Timing matters because the medicine needs to reach adequate concentrations in maternal tissues and amniotic fluid before birth. The target often discussed is at least four hours of intravenous prophylaxis before delivery, although treatment remains worthwhile when labour progresses faster. A short interval is not a reason to withhold antibiotics, and it should never delay urgent birth, fetal monitoring, resuscitation or other essential care.

Australian maternity services use local protocols based on national and international evidence. Screening approaches, laboratory reporting and antibiotic selections can differ between a metropolitan hospital in Melbourne, a private unit in Sydney and a regional service in northern Queensland. The practical aim is consistent: identify risk, start treatment promptly and communicate the newborn’s exposure clearly.

Why GBS Prevention Matters

Early-onset GBS disease usually appears in the first 24 hours after birth, though it can develop during the first week. A newborn may show respiratory distress, poor feeding, temperature instability, lethargy, grunting or abnormal colour. The illness can progress quickly, so prevention during labour and prompt neonatal assessment work together rather than serving as competing strategies.

Colonisation is intermittent. A negative swab at one point does not guarantee that GBS will be absent at birth, while a positive result does not mean the mother is ill. This explains why a maternity record should distinguish colonisation, GBS bacteriuria and a previous affected infant. Each carries different clinical implications, and a clear history helps the birth team act without avoidable delay.

Antenatal counselling should also place GBS in the wider context of infection prevention. Patients may be reviewing several issues at once, including HIV testing, hepatitis B status and vaccination. Resources discussing perinatal infection strategies can help clinicians explain why different infections require different tests, medicines and timing decisions.

Screening And Risk Assessment In Australia

Australian hospitals do not all organise GBS screening identically. Many services offer a vaginal–rectal swab late in pregnancy, commonly around 35–37 weeks, while some follow a risk-based model or use a local variation of culture and clinical assessment. The result should be available in the maternity record, with the collection date and laboratory interpretation visible to the team covering labour.

Indications for intrapartum antibiotic prophylaxis commonly include a positive late-pregnancy culture, GBS bacteriuria in the current pregnancy and a previous infant with confirmed invasive GBS disease. When the result is unknown, clinicians consider preterm labour, prolonged rupture of membranes, maternal fever and other factors specified by hospital policy. A patient who arrives in spontaneous labour without records should not be disadvantaged by missing paperwork; rapid history-taking and escalation to the senior maternity team are important.

Local geography can influence preparation. A family transferred from a remote Western Australian or Northern Territory community may arrive in Perth or Darwin without the complete pathology history, while a patient travelling from outer Melbourne may have records across public and private systems. Confirming results before term, documenting them in the electronic record and giving the patient a written plan can reduce treatment gaps during transfer.

Choosing And Starting The Antibiotic

Intravenous benzylpenicillin is generally the preferred first-line medicine when there is no relevant allergy. A common regimen uses a loading dose followed by repeated doses at four-hour intervals until birth, but the exact dose and redosing schedule must follow the hospital’s current antimicrobial guideline. Ampicillin may be used in some services. The first dose should be administered as soon as labour is established or membranes rupture when prophylaxis is indicated.

The four-hour interval is a goal, not a pass–fail boundary. If birth occurs after one dose, that dose still offers potential benefit. Staff should record the time of administration, drug, dose, route and any reaction. Repeated doses should be given while labour continues, with adjustments for renal impairment or other clinical factors when required.

A reported penicillin allergy deserves careful clarification. Nausea is not the same as anaphylaxis, and a remote, vague reaction may lead to a different option from documented airway compromise, hypotension or severe skin reactions. Cefazolin is commonly considered for patients at low risk of an immediate severe reaction. For high-risk allergy, clindamycin is appropriate only when the isolate is susceptible and the laboratory has performed the relevant testing; otherwise, vancomycin may be required under specialist or local protocol.

Timing Around Birth And Procedures

Clinicians should start prophylaxis promptly, yet antibiotics must not dictate unsafe obstetric timing. An urgent caesarean birth, fetal compromise, severe maternal illness or a need for operative delivery should proceed according to obstetric priorities. A patient with a planned caesarean birth before labour and before rupture of membranes generally does not need GBS-specific intrapartum prophylaxis, although standard surgical antibiotic prevention still applies.

When membranes rupture at term, the team balances GBS prevention with the management of labour, infection risk and the patient’s preferences. Antibiotics should be prepared without waiting for contractions to become intense or for a particular cervical dilation. In an induction, the medication plan should be built into the admission orders so that the first dose is not overlooked during busy transitions between antenatal care, birthing suite and theatre.

The birth team should also anticipate analgesia, cannulation difficulty and rapid labour. Many Australian families prefer to remain mobile, use showers or baths and limit unnecessary interventions, so intravenous access and medication discussions may need to be explained respectfully. Clear language helps: the antibiotic is intended to reduce newborn exposure to GBS, not to treat a maternal infection or guarantee that infection cannot occur.

Newborn Observation And Escalation

The newborn’s management depends on gestational age, clinical condition, maternal temperature, duration of ruptured membranes, the adequacy of prophylaxis and the hospital’s early-onset sepsis pathway. A well baby may need structured observation rather than automatic antibiotics. Signs of illness require immediate senior paediatric or neonatal review, investigations and treatment according to the local guideline.

Adequate exposure is often defined by a minimum period before birth, but clinical teams should not label prophylaxis “failed” simply because labour was brief. The record should state when the first dose was given and how many doses were administered. This information supports decisions in the postnatal ward, special care nursery or neonatal intensive care unit.

Resuscitation readiness remains essential because GBS prevention does not remove all causes of newborn compromise. Teams can align antibiotic documentation with neonatal resuscitation guidance, ensuring that the person caring for the newborn knows the maternal infection history while focusing first on breathing, circulation and temperature. In Australia, escalation pathways may involve a local special care nursery, a retrieval service or transfer to a tertiary centre such as the Royal Children’s Hospital or the Women’s and Children’s Hospital, depending on location.

Safe Systems And Antimicrobial Stewardship

Good GBS care depends on reliable systems rather than memory alone. Electronic alerts, antenatal result review, admission checklists and verbal handover can make the indication visible. Pathology laboratories should report susceptibility information clearly when resistant organisms or severe allergy affect drug choice. Private pathology providers and public hospital laboratories may use different portals, so staff need a dependable method for importing or confirming results.

Antibiotic stewardship means using prophylaxis for a defined indication, selecting the narrowest suitable medicine and stopping the GBS regimen after birth unless another infection requires continued treatment. Broad-spectrum treatment without a clear reason can contribute to adverse effects, resistance and disruption of the newborn microbiome. Documentation should include allergy assessment, indication, start time, doses and any adverse reaction.

Privacy is part of safe communication. Australian services must handle health information consistently with the Privacy Act 1988 and applicable state or territory requirements, while electronic records such as My Health Record have their own access and consent settings. A transfer summary should share clinically necessary GBS information without sending unrelated personal details. Families moving between Brisbane, regional New South Wales and interstate services benefit from a concise paper or digital birth plan that they can present when systems do not connect.

The COVID-19 pandemic showed how quickly staffing, transport and international supply chains can be disrupted. Planning for resilient maternity care includes maintaining essential antibiotics, training staff in allergy assessment, supporting rural retrieval networks and reviewing near-misses. Broader principles in resilient perinatal systems apply directly to GBS prevention: reliable communication and adaptable local services protect patients when routine pathways change.

Every Australian maternity service can strengthen this pathway by auditing the time from admission to first dose, reviewing missed indications and checking whether newborn teams receive complete handover. Clinicians should use their hospital’s current antimicrobial and neonatal policies, involve microbiology or infectious diseases when allergy or resistance is complex, and explain the plan to each family in plain language. Prompt, proportionate prophylaxis gives babies the best available protection while preserving safe, respectful and evidence-based birth care.